MassMutual Private Wealth & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.05K	Hold	288	–	–	﹤0.01%	1446
2026 Q1	$7.13K	Buy	288 +43	+18%	+$1.02K	﹤0.01%	1520
2025 Q4	$5.72K	Hold	245	–	–	﹤0.01%	1628
2025 Q3	$4.83K	Sell	245 -5	-2%	-$103	﹤0.01%	1686
2025 Q2	$5.42K	Sell	250 -14	-5%	-$330	﹤0.01%	1609
2025 Q1	$6.4K	Buy	264 +19	+8%	+$428	﹤0.01%	1484
2024 Q4	$5.11K	Hold	245	–	–	﹤0.01%	1527
2024 Q3	$4.87K	Hold	245	–	–	﹤0.01%	1395
2024 Q2	$3.79K	Hold	245	–	–	﹤0.01%	1409
2024 Q1	$3.9K	Hold	245	–	–	﹤0.01%	1349
2023 Q4	$4.12K	Buy	245 +67	+38%	+$916	﹤0.01%	1289
2023 Q3	$2.08K	Hold	178	–	–	﹤0.01%	1493
2023 Q2	$2.39K	Sell	178 -94	-35%	-$1.35K	﹤0.01%	1424
2023 Q1	$4.51K	Hold	272	–	–	﹤0.01%	1176
2022 Q4	$5K	Buy	272 +63	+30%	+$970	﹤0.01%	976
2022 Q3	$3K	Buy	+209	New	+$2.48K	﹤0.01%	1072
2022 Q1	–	Sell	-85	Closed	-$1K	–	1532
2021 Q4	$1K	Buy	+85	New	+$559	﹤0.01%	1194

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MassMutual Private Wealth & Trust's CPRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 288 shares worth $9.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

MassMutual Private Wealth & Trust first reported a position in CPRX in Q4 2021 and has held it in 17 quarters since. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

MassMutual Private Wealth & Trust held 288 shares of Catalyst Pharmaceutical worth $9.05K as of Q2 2026.
MassMutual Private Wealth & Trust left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1446 holding.
MassMutual Private Wealth & Trust first reported a position in Catalyst Pharmaceutical in Q4 2021 and has held it in 17 quarters since.
36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.